Ncats: service: mouse PK/PD study services for nnmt inhibitors: severable
Active Purchase Order Awarded
- Contract number
- 75N98026P01624
- Awardee
-
Pharmaron, Inc. UEI L8NQAFSTPSY9
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $50,300
Award facts
- Opportunity
-
- Mouse PK/PD Study Services for NNMT Inhibitors Solicitation · 75N98026Q00993 · Posted Aug 8, 2026
- Contract value 100% obligated
- $50,300.00 Current and potential, with all options
- Completion date 11% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 7 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences awarded a firm fixed-price purchase order to Pharmaron, Inc. valued at $50,300 on September 14, 2026, for mouse pharmacokinetic/pharmacodynamic study services on NNMT inhibitors. Work is performed in Rockville, Maryland. The contract requires single-dose oral and intravenous studies in mice across ten NNMT inhibitor test articles, with a sample size of three mice per time point, plasma concentration data collection, and pharmacokinetic parameter calculations. The contractor must deliver a final study report in Excel and/or PDF format within three weeks of study completion. Period of performance is up to three months from purchase order receipt. The award originated from an August 2026 competitive solicitation under FAR 12.603 (commercial products/services) that did not involve a small business set-aside.
Quick answers
Who was awarded contract 75N98026P01624?
75N98026P01624 was awarded to Pharmaron, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 14, 2026.
How much is contract 75N98026P01624 worth?
The government has obligated $50,300 on 75N98026P01624.
Which agency awarded contract 75N98026P01624?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01624, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N98026P01624 competed?
The extent of competition for 75N98026P01624 was competed under sap. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award